Risk of breast cancer after exposure to fertility drugs: Results from a large danish cohort study

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 7, 2007, Pages 1400-1407

  Jensen, Allan ^a,c   Sharif, Heidi ^a   Svare, Edith I ^a   Frederiksen, Kirsten ^a   Kjær, Susanne Krüger ^a,b  

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; FERTILITY PROMOTING AGENT; GONADORELIN; GONADOTROPIN; PROGESTERONE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; FOLLOW UP; HISTOLOGY; HUMAN; INFERTILITY; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADENOCARCINOMA; ADOLESCENT; ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; COHORT STUDIES; DENMARK; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INCIDENCE; INFERTILITY, FEMALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 34447504753     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0075     Document Type: Article

References (39)

1. Garland M, Hunter DJ, Colditz GA, et al. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 1998;147:636-43.
2. Kelsey JL, Gammon MD. Epidemiology of breast cancer. Epidemiol Rev 1990;12:228-40.
3. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
4. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001;2:133-40.
5. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
6. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
7. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
8. Brzezinski A, Peretz T, Mor-Yosef S, Schenker JG. Ovarian stimulation and breast cancer: is there a link? Gynecol Oncol 1994;52:292-5.
9. Jourdain O, Avril A, Mauriac L, et al. Breast cancer and in vitro fertilization. About 32 cases. Eur J Obstet Gynecol Reprod Biol 1996;67:47-52.
10. Unkila-Kallio L, Leminen A, Tiitnen A, Lehtovirta P, Wahlstrom T, Ylikorkala O. Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases. Acta Obstet Gynecol Scand 1997;76:177-81.
11. Ron E, Lunenfeld B, Menczer J, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987;125:780-90.
12. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586-90.
13. Braga C, Negri E, La Vecchia C, Parazzini F, Dal Maso L, Franceschi S. Fertility treatment and risk of breast cancer. Hum Reprod 1996;11:300-3.
14. Dor J, Lerner-Geva L, Rabinovici J, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324-7.
15. Modan B, Ron E, Lerner-Geva L, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998;147:1038-42.
16. Ricci E, Parazzini F, Negri E, Marsico S, La Vecchia C. Fertility drugs and the risk of breast cancer. Hum Reprod 1999;14:1653-5.
17. Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 2002;17:2209-13.
18. Lerner-Geva L, Geva E, Lessing JB, Chetrit A, Modan B, Amit A. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer 2003;13:23-7.
19. Lerner-Geva L, Keinan-Boker L, Blumstein T, et al. Infertility, ovulation induction treatments and the incidence of breast cancer - a historical prospective cohort of Israeli women. Breast Cancer Res Treat 2006;100:201-12.
20. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995;346:995-1000.
21. Gauthier E, Paoletti X, Clavel-Chapelon F. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 2004;19:2216-21.
22. Brinton LA, Scoccia B, Moghissi KS, et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 2004;19:2005-13.
23. Burkman RT, Tang MT, Malone KE, et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril 2003;79:844-51.
24. Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 1999;71:853-9.
25. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1995;4:437-40.
26. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of breast cancer in a cohort in infertile women. Gynecol Oncol 1996;60:3-7.
27. Prentice RL. A cose-cohort design for epidemiological cohort studies and disease prevention trials. Biometrika 1986;73:1-11.
28. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994;50:1064-72.
29. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999;52:1165-72.
30. Hack M, Brish M, Serr DM, Insler V, Salomy M, Lunenfeld B. Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after clomiphene therapy. JAMA 1972;220:1329-33.
31. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27.
32. Tjonneland A, Christensen J, Thomsen BL, et al. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer 2004;100:2328-37.
33. Chang KJ, Lee TT, Linares-Cruz G, Fournier S, de Lignieres B. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 1995;63:785-91.
34. Foidart JM, Colin C, Denoo X, et al. Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril 1998;69:963-9.
35. Kramer EA, Seeger H, Kramer B, Wallwiener D, Mueck AO. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells. Eur J Obstet Gynecol Reprod Biol 2006;129:77-83.
36. Healy DL, Venn A. Infertility medications and the risk of breast cancer. Fertil Steril 2003;79:852-4.
37. Mosgaard B, Lidegaard O, Andersen AN. Use of fertility drugs in Denmark 1973-1993. An analysis based on sale statistics. Acta Obstet Gynecol Scand 1995;74:614-8.
38. Available at Danish Medicines Agency's home page: http://www. laegemiddelstyrelsen.dk.
39. Brinton LA, Melton LJ III, Malkasian GD, Jr., Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989;129:712-22.